Jasper Hellweg
Stock Analyst at Argus Research
(2.11)
# 2,954
Out of 5,147 analysts
92
Total ratings
48.61%
Success rate
3.63%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintains: Buy | $360 → $400 | $388.16 | +3.05% | 1 | Feb 6, 2026 | |
| BAX Baxter International | Downgrades: Hold | n/a | $20.37 | - | 3 | Oct 31, 2025 | |
| ZTS Zoetis | Reiterates: Buy | $190 | $131.10 | +44.93% | 7 | Sep 9, 2025 | |
| BIIB Biogen | Downgrades: Hold | n/a | $191.82 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $503.90 | -20.62% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $134.46 | +11.56% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $48.66 | +23.30% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $781.67 | +49.68% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $496.83 | +10.70% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $208.45 | -59.22% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $37.45 | +233.78% | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $140 | $53.57 | +161.34% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $232.08 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $33.86 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $178.81 | +62.18% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $86.68 | +15.37% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $289.12 | +2.03% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.15 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $211.91 | -36.29% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $13.22 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $208.96 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $198.31 | - | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $27.97 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $529.70 | -70.74% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $62.29 | +44.49% | 1 | Sep 19, 2018 |
Amgen
Feb 6, 2026
Maintains: Buy
Price Target: $360 → $400
Current: $388.16
Upside: +3.05%
Baxter International
Oct 31, 2025
Downgrades: Hold
Price Target: n/a
Current: $20.37
Upside: -
Zoetis
Sep 9, 2025
Reiterates: Buy
Price Target: $190
Current: $131.10
Upside: +44.93%
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $191.82
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $503.90
Upside: -20.62%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $134.46
Upside: +11.56%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $48.66
Upside: +23.30%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $781.67
Upside: +49.68%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $496.83
Upside: +10.70%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $208.45
Upside: -59.22%
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $37.45
Upside: +233.78%
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $53.57
Upside: +161.34%
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $232.08
Upside: -
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $33.86
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $178.81
Upside: +62.18%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $86.68
Upside: +15.37%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $289.12
Upside: +2.03%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.15
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $211.91
Upside: -36.29%
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $13.22
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $208.96
Upside: -
Mar 24, 2020
Downgrades: Hold
Price Target: n/a
Current: $198.31
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $27.97
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $529.70
Upside: -70.74%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $62.29
Upside: +44.49%